Products
Investing
Resources
Support
Aarti Drugs Limited (AARTIDRUGS)
₹418.8
INR+4.30(+1.04%)
As of May 9, 2025 9:55:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹3676.36 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹3754.47 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
24.24
Forward P/E
Price to Earnings ratio based on forecasted earnings
18.90
PEG Ratio
Price/Earnings to Growth ratio
7.38
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
1.58
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
36.87%
Operating Margin
Operating income as a percentage of revenue
10.75%
Return on Equity
Net income as a percentage of shareholders' equity
13.37%
Revenue (TTM)
Total revenue over trailing 12 months
₹2330.26 Cr-8.1%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹297.48 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹16.62+1%
Balance Sheet
Total Cash
Total cash and short-term investments
₹29.56 Cr
Total Debt
Total short-term and long-term debt
₹590.10 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
46.18%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹312 - ₹635
Beta
Measure of stock's volatility compared to the market
0.48
Shares Outstanding
Total number of shares issued by the company
₹9.19 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.96%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.24%
Payout Ratio
Percentage of earnings paid as dividends
6.01%